Document Detail

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
MedLine Citation:
PMID:  23765253     Owner:  NLM     Status:  Publisher    
Kallikrein-related peptidases (KLK), which represent a major tissue-associated proteolytic system, stand for a rich source of biomarkers that may allow molecular classification, early diagnosis and prognosis of human malignancies as well as prediction of response or failure to cancer-directed drugs. International research points to an important role of certain KLKs in female and male urogenital tract malignancies, in addition to cancers of the lung, brain, skin, head and neck, and the gastrointestinal tract. Regarding the female/male urogenital tract, remarkably, all of the KLKs are expressed in the normal prostate, testis, and kidney whereas the uterus, the ovary, and the urinary bladder are expressing a limited number of KLKs only. Most of the information regarding KLK expression in tumour-affected organs is available for ovarian cancer; all of the 12 KLKs tested so far were found to be elevated in the malignant state, depicting them as valuable biomarkers to distinguish between the normal and the cancerous phenotype. In contrast, for kidney cancer, a series of KLKs was found to be downregulated, while other KLKs were not expressed. Evidently, depending on the type of cancer or cancer stage, individual KLKs may show characteristics of a Janus-faced behaviour, by either expanding or inhibiting cancer progression and metastasis.
J Dorn; J Bayani; G M Yousef; F Yang; V Magdolen; M Kiechle; E P Diamandis; M Schmitt
Related Documents :
24281193 - Pharyngeal cancer surveillance using narrow band imaging during conventional upper gast...
23169243 - A feces collection paper does not enhance participation in a fecal immunochemical test-...
12607853 - Effects of extraction and nonextraction treatment on class i and class ii subjects.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-6-13
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  110     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-6-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Prof. Dr. Manfred Schmitt, Klinische Forschergruppe der Frauenklinik der Technischen Universitaet Muenchen, Ismaninger Strasse 22, 81675 Muenchen, Germany, Tel.: +49 89 4140 2449, Fax: +49 89 4140 7410, E-mail:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
Next Document:  Computational Gibberellin-binding channel discovery unraveling the unexpected perception mechanism o...